These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33942928)

  • 21. Frequent plateletpheresis donations & its effect on haematological parameters: An observational study.
    Nayak S; Coshic P; Pandey RM; Chatterjee K
    Indian J Med Res; 2019 Nov; 150(5):468-476. PubMed ID: 31939390
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-donation telephonic interview of blood donors providing an insight into delayed adverse reactions: First attempt in India.
    Tiwari AK; Aggarwal G; Dara RC; Arora D; Srivastava K; Raina V
    Transfus Apher Sci; 2017 Apr; 56(2):141-146. PubMed ID: 27839968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and predictors of adverse reactions in plateletpheresis donors with the perspective of donor safety in a tertiary care hospital of Northern India.
    Solanki A; Katharia R; Singh A; Chauhan A; Chandra T; Sonker A; Agarwal P
    Asian J Transfus Sci; 2020; 14(1):44-48. PubMed ID: 33162705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donor safety in triple plateletpheresis: results from the German and Austrian Plateletpheresis Study Group multicenter trial.
    Heuft HG; Moog R; Fischer EG; Zingsem J;
    Transfusion; 2013 Jan; 53(1):211-20. PubMed ID: 22612302
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How Can We Improve Retention of the First-Time Donor? A Systematic Review of the Current Evidence.
    Bagot KL; Murray AL; Masser BM
    Transfus Med Rev; 2016 Apr; 30(2):81-91. PubMed ID: 26971186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of immediate adverse donation reactions on the return of volunteers undergoing platelet apheresis.
    de Farias CLG; Bassolli L; Mendrone-Junior A; de Araújo Arrais C; Duran A; Rocha V; de Almeida-Neto C
    Transfus Apher Sci; 2022 Aug; 61(4):103424. PubMed ID: 35346602
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Switching iron-deficient whole blood donors to plateletpheresis.
    O'Meara A; Infanti L; Sigle J; Stern M; Buser A
    Transfusion; 2012 Oct; 52(10):2183-8. PubMed ID: 22404849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allergic reactions in healthy plateletpheresis donors caused by sensitization to ethylene oxide gas.
    Leitman SF; Boltansky H; Alter HJ; Pearson FC; Kaliner MA
    N Engl J Med; 1986 Nov; 315(19):1192-6. PubMed ID: 2429183
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel approach to increasing inventory with the current panel: increasing donation frequency by asking for a different blood product.
    Bagot KL; Masser BM; White KM
    Transfusion; 2015 Jun; 55(6):1294-302. PubMed ID: 25652648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peripheral blood cell telomere length measurements indicate that hematopoietic stem cell turnover is not significantly increased in whole blood and apheresis PLT donors.
    Scheding S; Ersöz I; Hartmann U; Bartolvic K; Balabanov S; Salama A; Kanz L; Brümmendorf TH
    Transfusion; 2003 Aug; 43(8):1089-95. PubMed ID: 12869115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence, risk factors, and ferritin testing to mitigate iron depletion in male plateletpheresis donors.
    Spencer BR; Haynes JM; Notari EP; Stramer SL
    Transfusion; 2020 Apr; 60(4):759-768. PubMed ID: 32073674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequency of immediate adverse effects associated with apheresis donation.
    McLeod BC; Price TH; Owen H; Ciavarella D; Sniecinski I; Randels MJ; Smith JW
    Transfusion; 1998 Oct; 38(10):938-43. PubMed ID: 9767744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plateletpheresis in 90- to 110-pound donors using the CS-3000 blood cell separator.
    Buchholz DH; Squires JE; Herman JH; Ng AT; Anderson JK; Hedberg SL
    Transfusion; 1997 Jul; 37(7):715-8. PubMed ID: 9225935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Eighteen years experience of granulocyte donations-acceptable donor safety?
    Axdorph Nygell U; Sollén-Nilsson A; Lundahl J
    J Clin Apher; 2015 Oct; 30(5):265-72. PubMed ID: 25546372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective comparison of high-dose plateletpheresis with the latest apheresis systems on the same donors.
    Picker SM; Radojska SM; Gathof BS
    Transfusion; 2006 Sep; 46(9):1601-8. PubMed ID: 16965590
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in return behavior after an adverse event in Australian whole blood and plasma donors.
    Thijsen A; Masser B; Gemelli CN; Davison TE
    Transfusion; 2019 Oct; 59(10):3157-3163. PubMed ID: 31403178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sustained decreases in platelet count associated with multiple, regular plateletpheresis donations.
    Lazarus EF; Browning J; Norman J; Oblitas J; Leitman SF
    Transfusion; 2001 Jun; 41(6):756-61. PubMed ID: 11399815
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of iron stores in regular plateletpheresis donors.
    Page EA; Coppock JE; Harrison JF
    Transfus Med; 2010 Feb; 20(1):22-9. PubMed ID: 19903323
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in the Whole Blood Donor Population in South-West Germany: 2010 versus 2016.
    Müller-Steinhardt M; Weidmann C; Klüter H
    Transfus Med Hemother; 2017 Aug; 44(4):217-223. PubMed ID: 28924426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence rates of viral infections among repeat donors:are frequent donors safer?
    Schreiber GB; Glynn SA; Busch MP; Sharma UK; Wright DJ; Kleinman SH;
    Transfusion; 2001 Jun; 41(6):730-5. PubMed ID: 11399811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.